Acute Myeloid Leukemia Clinical Trials in Xiamen, Fujian
5 recruitingXiamen, Fujian, China
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia
Acute Myeloid Leukemia
Hutchmed316 enrolled53 locationsNCT06387069
Recruiting
Phase 1
Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
Acute Myeloid LeukemiaRelapseRefractory AML
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT06737523
Recruiting
Phase 1
Dose-escalation Study of D-CMG Regimen for the Treatment of Elderly Newly Diagnosed AML Patients
Acute Myeloid Leukemia
The First Affiliated Hospital of Xiamen University18 enrolled1 locationNCT06651866
Recruiting
Phase 2
Veneclax, Chidaniline Combined With Azacitidine Followed by Decitabine + MAG Regimen in the Treatment of Elderly Untreated AML
Acute Myeloid Leukemia
The First Affiliated Hospital of Xiamen University66 enrolled1 locationNCT06827899
Recruiting
Phase 3
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Shanghai Jiao Tong University School of Medicine222 enrolled9 locationsNCT05991908